Dr Reddys Laboratories Ltd Share Price Today - Live Blog for February 16, 2026

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.18%, and as of now, it's trading at 1270.40 per share. This upward trajectory is attracting keen interest from investors.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.18%. At this moment, it's actively trading at 1270.40, presenting an enticing opportunity for those in the market.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.07%, with its current market value per share resting at 1269.00. This development highlights the stock's appeal to investors.

After a significant 0.07% gain, Dr Reddys Laboratories Ltd's shares are now valued at 1269.00 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.23% gain, with the share price now at 1271.00. Notably, the stock's PE ratio stands at 19.1600, and its Return on Equity (ROE) is 16.0277.

With a remarkable 0.23% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at 1271.00. Notably, this stock has a Price-to-Earnings (PE) ratio of 19.1600, while the industry's PE ratio is 31.5474.

With a -0.09% decrease, Dr Reddys Laboratories Ltd's share price is now 1266.90. Investors should examine the factors driving this decline. The stock's PE ratio is 19.1600, whereas the industry PE ratio stands at 31.5474.

With a -0.09% decrease, Dr Reddys Laboratories Ltd's share price is now 1266.90. Investors should examine the factors driving this decline. The stock's PE ratio is 19.1600, whereas the industry PE ratio stands at 31.5474.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.09%, reaching a current market price of 1267.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd shares experienced a -0.09% reduction, with the current market price at 1267.00. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's share price has fallen by -0.32%, presenting both challenges and opportunities for investors. As of now, it's trading at 1264.00, and market participants are assessing the implications. The stock has a PE ratio of 19.1600, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd experienced a -0.32% downturn in its share price, and it's currently trading at 1264.00. This situation is generating interest among value investors who are evaluating the stock's potential.